← Evidence map

TrialClinical and translational science2025

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of HSK39297 in Chinese Healthy Subjects: A Phase 1 Clinical Trial.

Yuyang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40601394